Neurocrine Bio. (NBIX) PT Raised to $180 at Jefferies
Tweet
Share
E-mailGet Alerts NBIX Hot Sheet
Price: $157.79 +0.66%
Rating Summary:
30 Buy, 6 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 7 | Down: 11 | New: 32
Rating Summary:
30 Buy, 6 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 7 | Down: 11 | New: 32
Join SI Premium – FREE
Jefferies analyst Akash Tewari raised the price target on Neurocrine Bio. (NASDAQ: NBIX) to $180.00 (from $161.00) while maintaining a Buy rating.
You May Also Be Interested In
- Sprinklr Inc (CXM) PT Raised to $7.50 at Cantor Fitzgerald
- JPMorgan Downgrades ZTO Express (ZTO) to Overweight
- MongoDB (MDB) PT Lowered to $450 at BMO Capital
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
